Korro Bio (KRRO) Net Margin (2019 - 2025)
Korro Bio's (KRRO) quarterly Net Margin came in at 2020.74% in Q4 2025, down 186244.0% on a YoY basis from N/an in Q4 2024, and down 21.95% quarter-over-quarter from 1656.97% in Q3 2025.
Powered by 
Analysis
Korro Bio (KRRO) Net Margin (2019 - 2025) Analysis & Trends
Korro Bio (KRRO) has reported Net Margin for 5 consecutive years, with 2020.74% the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Margin fell 186244.0% year-over-year to 2020.74%; the trailing twelve-month figure through Jun 2026 stood at 3472.29% (down 229810.0% YoY), and the FY2025 full-year result was 1460.04%, up 144515.0% from the prior year.
- Net Margin eased to 2020.74% in Q4 2025 per KRRO's latest filing, from 1656.97% in the prior quarter.
- Across five years, Net Margin topped out at 158.3% in Q4 2024 and bottomed at 2020.74% in Q4 2025.
- Historically, Net Margin has averaged 1020.54% across 3 years, with a median of 917.14% in 2025.
- The sharpest annual moves came in 2021 and 2025: Net Margin slumped 11680 bps in 2021, then slumped 186244 bps in 2025.
- Over 3 years, Net Margin stood at 187.49% in 2021, then rose by 16 bps to 158.3% in 2024, then plunged by 1177 bps to 2020.74% in 2025.
- According to Business Quant data, Net Margin over the past three periods registered 2020.74%, 1656.97%, and 1765.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.69 Bn | 192.70 Bn | 7.24 Bn | 23.62% |
| 2 | Gilead Sciences | 179.87 Bn | 176.70 Bn | 6.22 Bn | -134.51% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 32.99% |
| 4 | Regeneron Pharmaceuticals | 81.70 Bn | 73.71 Bn | 3.93 Bn | 30.23% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 31.16% |
| 6 | Moderna | 54.28 Bn | 49.14 Bn | 52.00 Mn | -539.31% |
| 7 | Alnylam Pharmaceuticals | 33.02 Bn | 29.71 Bn | 992.69 Mn | 12.74% |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 3.56% |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | -20,152.98% |
| 10 | Korro Bio | 231.15 Mn | 116.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2,020.74% |
| Sep 30, 2025 | -1,656.97% |
| Jun 30, 2025 | -1,765.07% |
| Mar 31, 2025 | -917.14% |
| Dec 31, 2024 | -158.30% |
| Jun 30, 2021 | -187.49% |
| Mar 31, 2021 | -438.08% |
| Dec 31, 2020 | -102.83% |
| Sep 30, 2020 | -47.49% |
| Jun 30, 2020 | -70.69% |
| Mar 31, 2020 | -67.63% |
| Dec 31, 2019 | -117.50% |
| Sep 30, 2019 | -6.56% |